Literature DB >> 7548347

Effect of hypertensive diseases in pregnancy on birthweight, gestational duration, and small-for-gestational-age births.

C V Ananth1, A Peedicayil, D A Savitz.   

Abstract

We measured the impact of hypertensive disorders in pregnancy (chronic hypertension, pregnancy-induced hypertension, and eclampsia) on birthweight, gestational duration, and small-for-gestational-age births. We employed a retrospective cohort design using North Carolina birth certificate data for the years 1988-1990, with the analyses based on nearly 300,000 pregnancies. Women noted to have eclampsia during pregnancy had a substantially greater risk of delivering very-low-birthweight infants (birthweight < or = 1,499 gm; risk difference (RD) = 6.7%) and moderately-low-birthweight infants (1,500-2,499 gm; RD = 14.6%), and very preterm (gestational age < 33 weeks; RD = 7.1%) and moderately preterm (33-36 weeks; RD = 9.3%) births, compared with women without hypertension. Corresponding risk differences for these outcomes were 1.9% and 5.1% for very low and moderately low birthweight, and 1.6% and 3.0% for very preterm and moderately preterm for women with chronic hypertension. Risk differences were of similar magnitude for women with pregnancy-induced hypertension for these outcomes. Hypertensive disorders in pregnancy were associated with small-for-gestational-age infants, with risk differences of 5.1%, 3.5%, and 9.2% for chronic hypertension, pregnancy-induced hypertension, and eclampsia, respectively. The patterns of risk were similar for preterm births due to spontaneous onset of labor and those due to other precipitating events. We observed similar patterns for black and white women. Control for confounders through multivariable logistic regression models did not alter the observed patterns. In spite of the limited data quality, we found that hypertensive disorders in pregnancy substantially increase the risk of low birthweight, preterm births, and small-for-gestational-age births.

Entities:  

Mesh:

Year:  1995        PMID: 7548347     DOI: 10.1097/00001648-199507000-00011

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  32 in total

1.  The effect of expanding Medicaid prenatal services on birth outcomes.

Authors:  L M Baldwin; E H Larson; F A Connell; D Nordlund; K C Cain; M L Cawthon; P Byrns; R A Rosenblatt
Journal:  Am J Public Health       Date:  1998-11       Impact factor: 9.308

2.  Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants?

Authors:  Kristin Palmsten; Soko Setoguchi; Andrea V Margulis; Amanda R Patrick; Sonia Hernández-Díaz
Journal:  Am J Epidemiol       Date:  2012-03-22       Impact factor: 4.897

3.  Evaluation of low birthweight in African Americans.

Authors:  I Ruijter; J M Miller
Journal:  J Natl Med Assoc       Date:  1999-12       Impact factor: 1.798

4.  Maternal Hypertension, Antihypertensive Medication Use, and Small for Gestational Age Births in the National Birth Defects Prevention Study, 1997-2011.

Authors:  Sarah C Fisher; Alissa R Van Zutphen; Paul A Romitti; Marilyn L Browne
Journal:  Matern Child Health J       Date:  2018-02

5.  Maternal pregnancy-related hypertension and risk for hypertension in offspring later in life.

Authors:  Kristin Palmsten; Stephen L Buka; Karin B Michels
Journal:  Obstet Gynecol       Date:  2010-10       Impact factor: 7.661

6.  Impact of pregnancy-induced hypertension on stillbirth and neonatal mortality.

Authors:  Cande V Ananth; Olga Basso
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

7.  Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations.

Authors:  Alissa R Caton; Erin M Bell; Charlotte M Druschel; Martha M Werler; Angela E Lin; Marilyn L Browne; Louise-Anne McNutt; Paul A Romitti; Allen A Mitchell; Richard S Olney; Adolfo Correa
Journal:  Hypertension       Date:  2009-05-11       Impact factor: 10.190

8.  Evidence of placental haemorrhage and preterm delivery.

Authors:  J W Gargano; C B Holzman; P K Senagore; M L Reuss; D R Pathak; M A Williams; R Fisher
Journal:  BJOG       Date:  2010-01-14       Impact factor: 6.531

9.  Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsia.

Authors:  Kristin Palmsten; Sonia Hernández-Díaz; Bindee Kuriya; Daniel H Solomon; Soko Setoguchi
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-11       Impact factor: 4.794

10.  Pesticide exposure and hypertensive disorders during pregnancy.

Authors:  Tina M Saldana; Olga Basso; Donna D Baird; Jane A Hoppin; Clarice R Weinberg; Aaron Blair; Michael C R Alavanja; Dale P Sandler
Journal:  Environ Health Perspect       Date:  2009-06-04       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.